Bostwick D G, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast T H, Bose D, Harrison J, Young R H
Division of Pathology, Mayo Clinic, Rochester, MN 55905.
Hum Pathol. 1993 Aug;24(8):819-32. doi: 10.1016/0046-8177(93)90131-y.
Atypical adenomatous hyperplasia (AAH) is a localized proliferation of small glands within the prostate that may be mistaken for carcinoma. To determine the diagnostic criteria for separating AAH from carcinoma, seven observers independently evaluated 54 selected lesions from 44 transurethral resection specimens. Three patterns of glandular proliferation were observed, all arising in association with nodular hyperplasia: AAH (38 foci), atypical small acinar proliferation of uncertain significance (eight foci), and well-differentiated carcinoma (eight foci). Of 24 architectural and cytologic features evaluated, the following were useful in separating these three patterns: variation in nuclear size (14%, 22%, and 25%, respectively), mean nucleolar diameter (0.69 micron, 1.43 microns, and 1.78 microns, respectively), largest nucleolar diameter (mean, 1.66 microns, 2.71 microns, and 2.81 microns, respectively), percentage of nucleoli greater than 1 micron in diameter (17.6%, 58.1%, and 77.5%, respectively), crystalloids within suspicious glands (16%, 13%, and 75%, respectively), luminal basophilic mucinous secretions, infiltrative borders, discontinuity of the basal cell layer in AAH (compared with complete absence in carcinoma; shown with basal cell-specific anti-keratin monoclonal antibody 34 beta E12 immunostaining), and intact basement membrane in AAH (compared with discontinuity in carcinoma; shown with type IV collagen immunostaining). Features that could not reliably separate AAH from carcinoma included lesion shape, circumscription, multifocality, average gland size, variation in gland size and shape, nuclear shape, chromatin pattern, and amount and tinctorial quality of cytoplasm. Although the biologic significance of AAH is uncertain, its light microscopic appearance and immunophenotype allow it to be distinguished from carcinoma in most cases.
非典型腺瘤样增生(AAH)是前列腺内小腺体的局限性增生,可能被误诊为癌。为确定区分AAH与癌的诊断标准,7名观察者对44例经尿道切除标本中的54个选定病变进行了独立评估。观察到三种腺体增生模式,均与结节状增生相关:AAH(38个病灶)、意义不明确的非典型小腺泡增生(8个病灶)和高分化癌(8个病灶)。在评估的24个结构和细胞学特征中,以下特征有助于区分这三种模式:核大小变异(分别为14%、22%和25%)、平均核仁直径(分别为0.69微米、1.43微米和1.78微米)、最大核仁直径(平均分别为1.66微米、2.71微米和2.81微米)、直径大于1微米的核仁百分比(分别为17.6%、58.1%和77.5%)、可疑腺体内的类晶体(分别为16%、13%和75%)、管腔嗜碱性黏液性分泌物、浸润性边界、AAH中基底细胞层的连续性中断(与癌中完全缺失相比;用基底细胞特异性抗角蛋白单克隆抗体34βE12免疫染色显示)以及AAH中完整的基底膜(与癌中的连续性中断相比;用IV型胶原免疫染色显示)。不能可靠区分AAH与癌的特征包括病变形状、边界、多灶性、平均腺体大小、腺体大小和形状变异、核形状、染色质模式以及细胞质的量和染色质量。尽管AAH的生物学意义尚不确定,但其光镜表现和免疫表型在大多数情况下可使其与癌相区分。